Medical education: Do you know your audience?

June 16, 2008
Medical Communications, Sales and Marketing communications, medical education

Medical education has always been an important part of the mix within pharmaceutical marketing. The planning and development of high …

Latest news from Datamonitor

June 16, 2008
Medical Communications digi

'Conservative' pharmaceutical industry slow to take advantage of online marketing opportunitiesWhile the internet has altered the landscape in the retail …

Private executives to run NHS trusts

June 13, 2008

The government has sent a warning to failing NHS trusts that their management will be turned over to the private …

Januvia study shows hypoglycaemia benefit

June 13, 2008
Sales and Marketing

A new study of Merck Sharp & Dohme's Januvia showed it lowered the risk of hypoglycaemia, compared to an older …

Public needs help to be healthy, Kings Fund

June 13, 2008

The King's Fund has called for greater effort to be made by government to help people improve their health. The …

GSK’s Tyverb granted conditional licence in EU

June 13, 2008
Sales and Marketing

European regulators have given GlaxoSmithKline's Tyverb conditional approval, clearing it for launch but asking for more clinical data. Tyverb (lapatinib) …

Daiichi Sankyo acquires Ranbaxy

June 13, 2008
Sales and Marketing

Japanese company Daiichi Sankyo is set to take over Ranbaxy, the largest manufacturer of generic drugs in India. Ranbaxy will …

Doctors ‘scaremongering’ over polyclinics

June 10, 2008

The health secretary has hit back in the fight over polyclinics saying the BMA is not being honest with its …

Latest news from Datamonitor

June 10, 2008
Sales and Marketing

Pharmacovigilance solutions: essential for the future of healthcareAlthough many newer pharmacovigilance solutions are still in the nascent stages, and despite …

Think tank questions polyclinic plans

June 6, 2008

A government strategy to transform primary care in England has been dealt a blow by a respected think tank, which …

Erbitux set for first line treatment of colorectal cancer

June 5, 2008
Sales and Marketing Cancer, Merck Serono

Merck Serono's Erbitux looks set for approval in Europe as a first-line colon cancer treatment. Approved four years ago as …

Data boost for Avastin

June 5, 2008
Sales and Marketing

A new study has confirmed that Roche's Avastin significantly extends time without disease progression for women with metastatic breast cancer. …

Latest news from Datamonitor

June 3, 2008
Sales and Marketing

Drug distribution restricted as manufacturers attempt to guard supply chain Ideally, drug supply should be a simple and transparent chain …

Sanofi fights to block generic Plavix in Germany

June 3, 2008
Sales and Marketing

Sanofi-Aventis is taking legal action to prevent the launch of a generic competitor to its blockbuster Plavix in Germany. At …

Close to home: the UK’s regional NHS influencers

June 3, 2008
Sales and Marketing NICE, UK, healthcare, influencers, regional

With so much attention directed at NICE since the parliamentary health select committee reported on the organisation in January, it …

Roche increases stake in Chugai

May 30, 2008
Sales and Marketing

Roche is strengthening its hold over Japanese drug firm Chugai, increasing its stake in the company from 50.1% to 59.9%. …

A million more patients to get statins

May 30, 2008
Sales and Marketing

Statin prescribing could be set to increase massively once again following new NICE guidance on cholesterol-lowering treatments. An extra 1.5 …

Schering-Plough to exploit new NICE transparency

May 30, 2008
Sales and Marketing

NICE has recommended two anti-TNF treatments for ankylosing spondylitis, the painful and progressive rheumatic disease, but has excluded a third …

The Gateway to Local Adoption Series

Latest content